Foodborne Illnesses / Campylobacter /

Campylobacter References

  1. "Preventing Foodborne Illness: Campylobacteriosis." University of Florida IFAS Extension, 2018. Available at:
  2. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. (1999). Campylobacter jejuni--an emerging foodborne pathogen. Emerg Infect Dis. 5(1):28-35.
  3. Ang CW, et al. (2001). Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce Anti-GM1 and Anti-GQ1b Antibodies in rabbits. Infect Immun. 69(4):2462-9.
  4. Angulo FJ, Nargund VN, Chiller TC. (2004). Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med B Infect Dis Vet Public Health. 51(8-9):374-9.
  5. Angulo FJ, Baker NL, Olsen SJ, Anderson A, Barrett TJ. (2004). Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans. Semin Pediatr Infect Dis. 15(2):78-85.
  6. Blaser, M. J. "Campylobacter jejuni and Related Species," in Mandell, Bennett, and Dolan's Principles and Practice of Infectious Diseases, Fifth Edition, p. 2276–85 (2000).
  7. Blaser MJ, Reller LB. (1981). Campylobacter Enteritis. N Engl J Med. 305:1444-52.
  8. Blaser MJ. (1997). Epidemiologic and clinical features of Campylobacter jejuni Infections. J Infect Dis. 176 Suppl 2:S103-5.
  9. Buzby JC, Roberts T. (2009). The Economics of Enteric Infections: Human Foodborne Disease Costs. Gastroenterology. 136(6):1851-62.
  10. "Bacterial Foodborne Disease: Medical Costs and Productivity Losses." USDA Economic Research Service, 1996. Available at:
  11. "Campylobacter (Campylobacteriosis), Questions & Answers." Centers for Disease Control and Prevention, 2019. Available at:
  12. "Preliminary FoodNet Data on the Incidence of Foodborne Illnesses --- Selected Sites, United States, 1999." MMWR. Available at:
  13. "Preliminary FoodNet Data on the Incidence of Infection with Pathogens Transmitted Commonly Through Food --- 10 States, 2006. MMWR. Available at:
  14. "Preliminary FoodNet Data on the Incidence of Infection With Pathogens Transmitted Commonly Through Food --- 10 States, 2009." MMWR. Available at:
  15. "Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016-2019. MMWR. Available at:
  16. "Foodborne Pathogens: Risks and Consequences." Council for Agricultural Science and Technology. Available at:
  17. Dai L, Sahin O, Grover M, Zhang Q. (2020). New and alternative strategies for the prevention, control, and treatment of antibiotic-resistant Campylobacter. Translational Research. 223(12):76-88.
  18. Facciolà A, et al. (2017). Campylobacter: from microbiology to prevention. J Prev Med Hyg. 58(2), E79-E92.
  19. Fang G, Araujo V, Guerrant RL. (1991). Enteric infections associated with exposure to animals or animal products. Infect Dis Clin North Am. 5(3):681-701.
  20. Fey PD, et al. (2000). Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med. 342(17):1242-9.
  21. Fischer GH, Paterek E. Campylobacter. [Updated 2020 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from:
  22. Fitzgerald C, et al. (2016). Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from Stool. J Clin Microbiol. 54(5):1209-15.
  23. "Bad Bug Book (Second Edition)." Food and Drug Administration, 2012. Available at:
  24. "Safe Food Handling." Food and Drug Administration, 2017. Available at:
  25. "2019 Summary Report On Antimicrobials Sold or Distributed for Use in Food-Producing Animals." Food and Drug Administration Center for Veterinary Medicine. Available at:
  26. Geissler AL, et al. (2017). Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2017. Clin Infect Dis. 65(10):1624-31.
  27. Glynn MK, et al. (1998). Emergence of Multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. N Engl J Med. 338(19):1333-8.
  28. Goossens H, et al. (1995). Investigation of an outbreak of Campylobacter upsaliensis in day-care-centers in Brussels -- analysis of relationships among isolates by phenotypic and genotypic typing methods. J Infect Dis. 172:1298-1305.
  29. Gottlieb SL, et al. (2006). Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policy. Clin Infect Dis. 42(1):29-36.
  30. Heimesaat MM, Backert S, Alter T, Bereswill S. (2021). Human Campylobacteriosis--A Serious Infectious Threat in a One Health Perspective. Curr Top Microbiol Immunol. 431: 1-23.
  31. Hoffmann S, Batz MB, Morris Jr, JG. (2012). Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 75(7):1292-302.
  32. "Economic Burden of Major Foodborne Illnesses Acquired in the United States" USDA, Economic Research Service, 2015. Available at:
  33. Igwaran A, Okoh AI. (2019). Human campylobacteriosis: A public health concern of global importance. Heliyon. 5(11):e02814.
  34. Lanier WA, Hale KR, Geissler AL, Dewey-Mattia D. (2018). Chicken Liver-Associated Outbreaks of Campylobacteriosis and Salmonellosis, United States, 2000-2016: Identifying Opportunities for Prevention. Foodborne Pathog Dis. 15(11):726-33.
  35. McCrea BA, et al. (2006). Prevalence of Campylobacter and Salmonella Species on Farm, After Transport, and at Processing in Specialty Market Poultry. Poultry Science. 85:136-43.
  36. Mungai EA, Behravesh CB, Gould LH. (2015). Increased Outbreaks Associated with Nonpasteurized Milk, United States, 2007-2012. Emerg Infect Dis. 21(1):119-22.
  37. Penner JL. (1988). The genus Campylobacter: A decade of progress. Clin Microbiol Rev. 1(2):157-72.
  38. Henley SC, Launchi N, Henley SC. (2018). Survival of Salmonella on raw poultry exposed to 10% lemon juice and vinegar washes. Food Control. 94(12):229-32.
  39. Rees JH, Soudain SE, Gregson NA, Hughes RA. (1995). Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 333(21):1374-9.
  40. Roberts T. (1989). Human Illness Costs of Foodborne Bacteria. Am J Agric Econ. 71(2):468-74.
  41. Same RG, Tamma PD. (2018). Campylobacter Infections in Children. Pediatr Rev. 39(11): 533-41.
  42. Scallan Walter EJ, Crim SM, Bruce BB, Griffin PM. (2019). Postinfectious Irritable Bowel Syndrome After Campylobacter Infection. Am J Gastroenterol. 114(10):1649-56.
  43. Scallan Walter EJ, Crim SM, Bruce BB, Griffin PM. (2020). Incidence of Campylobacter-Associated Guillain-Barré Syndrome Estimated from Health Insurance Data. Foodborne Pathog Dis. 17(1):23-8.
  44. Sheppard SK, Maiden MCJ. (2015). The evolution of Campylobacter jejuni and Campylobacter coli. Cold Spring Harb Perspect Biol. 7(8):a018119.
  45. Smith KE, et al. (1999). Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med. 340(20):1525-32.
  46. Tauxe, R. "Epidemiology of Campylobacter jejuni infections in the United States and other industrial nations," in Nachamkin, Blaser, and Tompkins' Campylobacter jejuni: Current and Future Trends, p. 9-12 (1992).
  47. "Antibiotic Resistance Threats in the United States, 2019." Centers for Disease Control and Prevention. Available at:
  48. "FDA Food Code 2017." Food and Drug Administration. Available at:
  49. "Safe Minimum Internal Temperature Chart." USDA Food Safety and Inspection Service, 2020. Available at:
  50. "Nationwide Broiler Chicken Microbiological Baseline Data Collection Program." USDA Food Safety and Inspection Service, 1996.
  51. "Nationwide Microbiological Baseline Data Collection Program: Young Chicken Survey." USDA Food Safety and Inspection Service, 2009.
  52. "The Nationwide Microbiological Baseline Data Collection Program: Young turkey Survey, August 2008 - July 2009." USDA Food Safety and Inspection Service. Available at:
  53. Wallinga D. (2002). Antimicrobial use in animal feed: an ecological and public health problem. Minn Med. 85(10):12-6.
  54. "Expert Reviews on the NARMS Program." Food and Drug Administration, 2005. Available at: